Holen Sie sich die Stockscreener-App
313.15
2.24%
-7.16
Handel nachbörslich:
313.15
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Protein Engineering Market Projected to Reach USD 7.39 Billion by 2032 with a CAGR of 14.72% - GlobeNewswire Inc.
Mawer Investment Management Ltd. Purchases 84,237 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Genomic Biomarker Market 2024 Opportunity, Challenge, - openPR
Laboratory Mixer Market Strong Industry Growth, Business - openPR
Research Antibodies Market Report Outlines Revenue Share, SWOT - openPR
Genomic Biomarker Market Dynamics and Forecast Comprehensive - openPR
Bio-Rad Laboratories, Inc. (NYSE:BIO) Stake Lowered by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Clinical Diagnostics Market to Reach $ 110.0 Billion by 2031 | - openPR
Multiplexed Diagnostics Market Share, Trends, Top Players, - openPR
Apoptosis Assays Market Analysis By Top KeyplayersMerck, - openPR
High-throughput Screening Technology Market Size and Regional An - News Channel Nebraska
Principal Financial Group Inc. Increases Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges - BioProcess Insider
Short Interest in Bio-Rad Laboratories, Inc. (NYSE:BIO) Declines By 20.8% - MarketBeat
Chromatography Systems Market Industry Detailed Exploration, - openPR
VAN ECK ASSOCIATES CORP's Strategic Acquisition in Bio-Rad Labor - GuruFocus.com
Chiral Chromatography Columns Market Overall Study Report - openPR
Dental Services Market Overall Study Report 2024-2032 | Agilent - openPR
Genomics Market Overall Study Report 2024-2032 | Agilent - openPR
SEC Form SC 13G filed by Bio-Rad Laboratories Inc. - Quantisnow
Entropy Technologies LP Acquires Shares of 4,200 Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
4,200 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Bought by Entropy Technologies LP - MarketBeat
Bio-Rad Demonstrates Leadership Position in the Oncology Market at Association for Molecular Pathology 2024 - Technology Networks
Protein A Resin Market Growth, Size, Trends, Shares, By Top - openPR
Brokerages Set Bio-Rad Laboratories, Inc. (NYSE:BIO) Target Price at $391.80 - MarketBeat
Lung Cancer Diagnostics Market Anticipated for Positive Growth - openPR
Biochips Market Is Booming Worldwide 2024-2031 | Illumina, - openPR
Bio-Rad Laboratories: This Undervalued Stock Offers Investors a Rare Combination - Morningstar
ICICI Prudential Asset Management Co Ltd Raises Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity? - Insider Monkey
PCR Systems Market Growth, Industry Development and Forecast - openPR
Thalassemia Testing Market Ready to Rise Sharply On Superior - openPR
Bio-Rad demonstrates leadership position in the oncology market at Association for Molecular Pathology 2024 - Cambridge Network
Biosensors Market Is Booming Worldwide 2024-2031 | Bio-Rad - openPR
Biomarker Testing Market: Global Size, Share, Growth Trends, - openPR
Neuroscience Antibodies And Assays Market Forecasted for Major - openPR
Amalgamated Bank Has $3.02 Million Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Hemoglobinopathies Market Size, Growth Opportunities 2031 - openPR
Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 52-Week HighHere's What Happened - MarketBeat
Rovin Capital UT ADV Invests $669,000 in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Monoclonal Antibody Diagnostic Reagents Market Is Booming - openPR
Transfer Membrane Market Size, Insights 2031 by Key Vendors- - openPR
Kornitzer Capital Management Inc. KS Acquires 3,564 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
StarBright Yellow 561: A reliable alternative to PE-tandem dyes - News-Medical.Net
Custom Antibody Market Growth, Drivers, and Opportunities – Exclusive Report by MarketsandMarkets™ - WICZ
[Latest] Global Cancer Cell Analysis Market Size/Share Worth USD 23.31 Billion by 2033 at a 8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
Electroporation Instruments And Consumables Market: Global - openPR
Bio-Rad's SWOT analysis: stock outlook amid operational gains, sector headwinds - Investing.com
Harbor Capital Advisors Inc. Raises Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Vanguard Group Inc's Strategic Reduction in Bio-Rad Laboratories Inc Shares - GuruFocus.com
Interpreting Bio-Rad (BIO) International Revenue Trends - Yahoo Finance
A Look At The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO) - Simply Wall St
Epigenetics Market Types and Applications, Drivers, Ongoing - openPR
Veritas Asset Management LLP Has $363.51 Million Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
StockNews.com Upgrades Bio-Rad Laboratories (NYSE:BIO) to "Buy" - MarketBeat
Bio-Rad stock hits 52-week high at $365.65 amid robust growth - Investing.com Australia
Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates - Yahoo Finance
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q3 2024 Earnings Call Transcript - Insider Monkey
BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket - MSN
Bio-Rad stock hits 52-week high at $365.65 amid robust growth By Investing.com - Investing.com South Africa
Bio-Rad Laboratories Inc (BIO) Shares Up 3.17% on Nov 1 - GuruFocus.com
Bio-Rad Laboratories (NYSE:BIO) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Bio-Rad net sales increase 2.8% to USD 649.7M in Q3 FY 24 - Medical Buyer
Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023) - Yahoo Finance
DekaBank Deutsche Girozentrale Has $4.03 Million Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):